Positive Trends In The Treatment Of Leukemia And Lymphoma.
Clinicians have made strange advances in treating blood cancers with bone marrow and blood curb room transplants in recent years, significantly reducing the risk of treatment-related complications and death, a different study shows. Between the early 1990s and 2007, there was a 41 percent drop in the overall jeopardize of death in an analysis of more than 2,500 patients treated at Fred Hutchinson Cancer Center in Seattle, a chairwoman in the field of blood cancers and other malignancies acnezine. Researchers from the Fred Hutchinson Cancer Center, who conducted the study, also distinguished dramatic decreases in treatment complications such as infection and organ damage.
The weigh was published in the Nov 24, 2010 issue of the New England Journal of Medicine. "We have made gross strides in understanding this very complex procedure and have yielded quite spectacular results," said ruminate on senior author Dr George McDonald, a gastroenterologist with Hutchinson and a professor of pharmaceutical at the University of Washington, in Seattle problem solutions. "This is one of the most complex procedures in medicine and we have found out a lot of complications we didn't before".
Dr Mitchell Smith, head of the lymphoma service at Fox Chase Cancer Center in Philadelphia, feels the mongrel positive trend - if not the exact numbers - can be extrapolated to other suffering centers. "Most of the things that they've been doing have been generally adopted by most transfer units, although you do have to be careful because they get a select patient population and they are experts. The smaller centers that don't do as many procedures may not get the call for same results, but the trend is clearly better".
Treatment of high-risk blood cancers such as leukemia, lymphoma and myeloma was revolutionized in the 1970s with the introduction of allogeneic blood or bone marrow transplantation. Before this advance, patients with blood cancers had far more narrow options. The high-dose chemotherapy or emanation treatments designed to liquidate blood cancer cells (which divide faster than plain cells) often damaged or destroyed the patient's bone marrow, leaving it unable to produce the blood cells needed to gain oxygen, fight infection and stop bleeding.
Transplanting healthy stem cells from a benefactress into the patient's bone marrow - if all went well - restored its power to produce these vital blood cells. While the psychotherapy met with great success, it also had a lot of serious side effects, including infections, element damage and graft-versus-host disease (GVHD), which were severe enough to prevent older and frailer patients from undergoing the procedure. But the late 40 years has seen a lot of improvements in managing these problems.
